732 related articles for article (PubMed ID: 22739038)
1. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
2. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
3. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
Wu D; Chen WQ; Li R; Wang Y
Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234
[TBL] [Abstract][Full Text] [Related]
5. Diquafosol ophthalmic solution for dry eye treatment.
Nakamura M; Imanaka T; Sakamoto A
Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study.
Yamaguchi M; Nishijima T; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Ohashi Y
Adv Ther; 2014 Nov; 31(11):1169-81. PubMed ID: 25376447
[TBL] [Abstract][Full Text] [Related]
7. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients.
Takamura E; Tsubota K; Watanabe H; Ohashi Y;
Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501
[TBL] [Abstract][Full Text] [Related]
9. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
Keating GM
Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
[TBL] [Abstract][Full Text] [Related]
10. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.
Kamiya K; Nakanishi M; Ishii R; Kobashi H; Igarashi A; Sato N; Shimizu K
Eye (Lond); 2012 Oct; 26(10):1363-8. PubMed ID: 22878452
[TBL] [Abstract][Full Text] [Related]
12. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
13. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
[TBL] [Abstract][Full Text] [Related]
14. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.
Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J
Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
16. Effects of topical diquafosol pretreatment on intraoperative corneal wetting.
Miyake G; Ota I; Miyake K; Zako M; Iwaki M
J Cataract Refract Surg; 2014 Oct; 40(10):1682-8. PubMed ID: 25175269
[TBL] [Abstract][Full Text] [Related]
17. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
Koh S; Maeda N; Ikeda C; Oie Y; Soma T; Tsujikawa M; Watanabe H; Nishida K
Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298
[TBL] [Abstract][Full Text] [Related]
18. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
[TBL] [Abstract][Full Text] [Related]
19. Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.
Lee H; Kim SM; Choi S; Seo KY; Kim EK; Kim TI
Clin Exp Optom; 2017 Nov; 100(6):590-594. PubMed ID: 28222481
[TBL] [Abstract][Full Text] [Related]
20. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
